Jonathan W. Astin

2.9k total citations
49 papers, 1.6k citations indexed

About

Jonathan W. Astin is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Jonathan W. Astin has authored 49 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 23 papers in Cell Biology and 20 papers in Oncology. Recurrent topics in Jonathan W. Astin's work include Zebrafish Biomedical Research Applications (15 papers), Lymphatic System and Diseases (14 papers) and Hippo pathway signaling and YAP/TAZ (8 papers). Jonathan W. Astin is often cited by papers focused on Zebrafish Biomedical Research Applications (15 papers), Lymphatic System and Diseases (14 papers) and Hippo pathway signaling and YAP/TAZ (8 papers). Jonathan W. Astin collaborates with scholars based in New Zealand, Australia and United Kingdom. Jonathan W. Astin's co-authors include Philip S. Crosier, Kathryn E. Crosier, Christopher J. Hall, Catherine D. Nobes, Maria Vega Flores, June P. Misa, Kazuhide S. Okuda, Shereen Kadir, Leslie E. Sanderson and Jennifer Batson and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Jonathan W. Astin

46 papers receiving 1.6k citations

Peers

Jonathan W. Astin
Phillip S. Leventhal United States
Derril H. Willard United States
Kyun Heo South Korea
Osvaldo Rey United States
David X. Liu United States
Phillip S. Leventhal United States
Jonathan W. Astin
Citations per year, relative to Jonathan W. Astin Jonathan W. Astin (= 1×) peers Phillip S. Leventhal

Countries citing papers authored by Jonathan W. Astin

Since Specialization
Citations

This map shows the geographic impact of Jonathan W. Astin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan W. Astin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan W. Astin more than expected).

Fields of papers citing papers by Jonathan W. Astin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan W. Astin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan W. Astin. The network helps show where Jonathan W. Astin may publish in the future.

Co-authorship network of co-authors of Jonathan W. Astin

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan W. Astin. A scholar is included among the top collaborators of Jonathan W. Astin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan W. Astin. Jonathan W. Astin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kakadia, Purvi M., Anassuya Ramachandran, Alexander Tups, et al.. (2025). A light-regulated circadian timer optimizes neutrophil bactericidal activity to boost daytime immunity. Science Immunology. 10(107). eadn3080–eadn3080. 4 indexed citations
2.
Kim, Jun‐Dae, Jonathan W. Astin, Philip S. Crosier, et al.. (2025). APOA1 binding protein promotes lymphatic cell fate and lymphangiogenesis by relieving caveolae-mediated inhibition of VEGFR3 signaling. Nature Communications. 16(1). 9286–9286.
3.
Steel, Tasha R., et al.. (2025). The Chemistry of Anticancer Mononuclear and N‐Bridged Dinuclear 8‐Aminoquinoline Half‐sandwich Metal Complexes. Chemistry - A European Journal. 31(23). e202404366–e202404366. 1 indexed citations
4.
Choi, Sy Bing, Satoshi Ogawa, Ishwar S. Parhar, et al.. (2024). Canthin-6-One Inhibits Developmental and Tumour-Associated Angiogenesis in Zebrafish. Pharmaceuticals. 17(1). 108–108. 3 indexed citations
5.
Astin, Jonathan W., et al.. (2023). Microinjection of β-glucan Into Larval Zebrafish (<em>Danio rerio</em>) for the Assessment of a Trained-Like Immunity Phenotype. BIO-PROTOCOL. 13(23). e4888–e4888. 1 indexed citations
6.
Hall, Christopher J., Jonathan W. Astin, Jeff S. Mumm, & David F. Ackerley. (2022). A New Transgenic Line for Rapid and Complete Neutrophil Ablation. Zebrafish. 19(3). 109–113. 4 indexed citations
7.
Astin, Jonathan W., et al.. (2022). Towards a new model of trained immunity: Exposure to bacteria and β-glucan protects larval zebrafish against subsequent infections. Developmental & Comparative Immunology. 132. 104400–104400. 17 indexed citations
8.
Kanamala, Manju, et al.. (2020). Targeting Drugs to Larval Zebrafish Macrophages by Injecting Drug-Loaded Liposomes. Journal of Visualized Experiments. 2 indexed citations
9.
Parveen, Shahida, Muhammad Hanif, Euphemia Leung, et al.. (2019). Anticancer organorhodium and -iridium complexes with low toxicity in vivo but high potency in vitro: DNA damage, reactive oxygen species formation, and haemolytic activity. Chemical Communications. 55(80). 12016–12019. 48 indexed citations
10.
Wu, Zimei, Manju Kanamala, Bregina Pool, et al.. (2019). Liposome-Mediated Drug Delivery in Larval Zebrafish to Manipulate Macrophage Function. Zebrafish. 16(2). 171–181. 10 indexed citations
11.
Shrestha, Shikshya, Woohyun Cho, Mark A. Perrella, et al.. (2019). Glycogen synthase kinase 3-β inhibition induces lymphangiogenesis through β-catenin-dependent and mTOR-independent pathways. PLoS ONE. 14(4). e0213831–e0213831. 9 indexed citations
12.
Hall, Christopher J., Leslie E. Sanderson, Bregina Pool, et al.. (2018). Blocking fatty acid–fueled mROS production within macrophages alleviates acute gouty inflammation. Journal of Clinical Investigation. 128(5). 1752–1771. 60 indexed citations
13.
Astin, Jonathan W., Kathryn E. Crosier, Philip S. Crosier, et al.. (2017). The innate immune cell response to bacterial infection in larval zebrafish is light-regulated. Scientific Reports. 7(1). 12657–12657. 21 indexed citations
14.
Koltowska, Katarzyna, Scott Paterson, Neil I. Bower, et al.. (2015). mafba is a downstream transcriptional effector of Vegfc signaling essential for embryonic lymphangiogenesis in zebrafish. Genes & Development. 29(15). 1618–1630. 49 indexed citations
15.
Astin, Jonathan W., Stephen M. F. Jamieson, Maria Vega Flores, et al.. (2014). An In Vivo Antilymphatic Screen in Zebrafish Identifies Novel Inhibitors of Mammalian Lymphangiogenesis and Lymphatic-Mediated Metastasis. Molecular Cancer Therapeutics. 13(10). 2450–2462. 30 indexed citations
16.
Batson, Jennifer, Jonathan W. Astin, & Catherine D. Nobes. (2013). Regulation of contact inhibition of locomotion by Eph–ephrin signalling. Journal of Microscopy. 251(3). 232–241. 21 indexed citations
17.
Bower, Neil I., Tara Karnezis, Jan Kazenwadel, et al.. (2013). Arap3 is dysregulated in a mouse model of hypotrichosis–lymphedema–telangiectasia and regulates lymphatic vascular development. Human Molecular Genetics. 23(5). 1286–1297. 26 indexed citations
18.
Hall, Christopher J., Jonathan W. Astin, Maria Vega Flores, et al.. (2013). Immunoresponsive Gene 1 Augments Bactericidal Activity of Macrophage-Lineage Cells by Regulating β-Oxidation-Dependent Mitochondrial ROS Production. Cell Metabolism. 18(2). 265–278. 200 indexed citations
19.
Okuda, Kazuhide S., Jonathan W. Astin, June P. Misa, et al.. (2012). lyve1 expression reveals novel lymphatic vessels and new mechanisms for lymphatic vessel development in zebrafish. Development. 139(13). 2381–2391. 156 indexed citations
20.
Astin, Jonathan W., Jennifer Batson, Shereen Kadir, et al.. (2010). Competition amongst Eph receptors regulates contact inhibition of locomotion and invasiveness in prostate cancer cells. Nature Cell Biology. 12(12). 1194–1204. 201 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026